Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare professionals to mitigate various forms of discomfort, including both persistent (chronic) and sudden (acute) pain. Established in 2002, the firm is headquartered in Scottsdale, Arizona.
Subscribe to see Electromedical Technologies, Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Electromedical Technologies, Inc is a medical devices company headquartered in Scottsdale, United States. It is publicly listed (EMED) with a market capitalisation of $373,229. Xcout tracks 8 named people at Electromedical Technologies, Inc, including Matthew N. Wolfson (Chief Executive Officer, President, Chairman, Chief Financial Officer, Treasurer & Secretary).
2 more named people on record for Electromedical Technologies, Inc, with roles, board committees and tenure — see the full roster →
A few of Electromedical Technologies, Inc's closest competitors — see the full list of competitors and alternatives →
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Elite Medical Technologies LLC is a private label contract manufacturer of medical devices. The company provides vertically integrated manufacturing services for medical device clients.
Encore Medical Inc. is a U.S.-based medical technology enterprise. Operating from its headquarters in Eagan, Minnesota, the company is dedicated to designing, producing, and distributing advanced, specialized devices for both healthcare providers and patients. These innovative tools are utilized in diverse settings, from professional clinics to private homes. Encore Medical's stock is publicly traded on the NYSE Arca exchange, under the ticker symbol EMI.
Exlites Holdings International Inc. is an innovator, manufacturer, and distributor of FDA-approved medical devices and consumer healthcare products. The company serves care teams, hospital leaders, and business clients by providing solutions in categories such as weight loss, muscle toning, and pain reduction.
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.